ResearchMoz

Browse reports in Diseases & Conditions

Displaying 1 to 30 (of 235 records)
Global Crohn's Disease (CD) Market 2015-2019
Mar 2015   |   By - Technavio
About CD CD is an ongoing condition that causes inflammation of the digestive tract or the GI tract. CD may also be named as ileitis, granulomatous enteritis or colitis, regional enteritis, or terminal ileitis. The exact etiology of CD is unknown. Usually, CD affects the small intestine and the beginning of the large intestine. However, the disease can disturb any part of the GI...
$3000
Genetic Disorders Deals and Alliances of 2014
Mar 2015   |   By - Current Partnering
The Genetic Disorders Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you...
$1495
Autoimmune Partnering Terms and Agreements
Mar 2015   |   By - Current Partnering
The Autoimmune Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the autoimmune partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in autoimmune partnering deals Average deal terms for headline, upfront and royalty by stage of development Autoimmune partnering agreement...
$2995
Breast Cancer Partnering 2010-2015
Mar 2015   |   By - Current Partnering
The Breast Cancer Partnering 2010-2015 report provides understanding and access to the breast Cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in breast cancer partnering deals Top breast cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The...
$1795
Gastric Cancer Partnering 2010-2015
Mar 2015   |   By - Current Partnering
The Gastric Cancer Partnering 2010-2015 report provides understanding and access to the gastric cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in gastric cancer partnering deals Top gastric cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The...
$795
Multiple Myeloma Partnering 2010-2015
Mar 2015   |   By - Current Partnering
The Multiple Myeloma Partnering 2010-2015 report provides understanding and access to the multiple myeloma partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in multiple myeloma partnering deals Top multiple myeloma deals by value Deals listed by company A-Z, industry sector, stage of development, technology type...
$995
Migraine Partnering 2010-2015
Mar 2015   |   By - Current Partnering
The Migraine Partnering 2010-2015 report provides understanding and access to the migraine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in migraine partnering deals Top migraine deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Migraine Partnering...
$795
Coronary Artery Disease Partnering 2010-2015
Mar 2015   |   By - Current Partnering
The Coronary Artery Disease Partnering 2010-2015 report provides understanding and access to the coronary artery disease partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in coronary artery disease partnering deals Top coronary artery disease deals by value Deals listed by company A-Z, industry sector, stage of development,...
$795
Epilepsy Partnering 2010-2015
Mar 2015   |   By - Current Partnering
The Epilepsy Partnering 2010-2015 report provides understanding and access to the epilepsy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in epilepsy partnering deals Top epilepsy deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Epilepsy Partnering 2010-2015...
$795
Pain Partnering 2010-2015
Mar 2015   |   By - Current Partnering
The Pain Partnering 2010-2015 report provides understanding and access to the pain partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in pain partnering deals Top pain deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Pain Partnering 2010-2015 provides...
$1795
Cancer Symptoms Partnering 2010-2015
Mar 2015   |   By - Current Partnering
The Cancer Symptoms Partnering 2010-2015 report provides understanding and access to the Cancer symptoms partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer symptoms partnering deals Top cancer symptoms deals by value Deals listed by company A-Z, industry sector, stage of development, technology type...
$995
Epilepsy - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Epilepsy Pipeline Review, H1 2015, provides an overview of the Epilepsys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Epilepsy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type,...
$2000
Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Human papillomavirus (HPV) Associated Cancer Pipeline Review, H1 2015, provides an overview of the Human papillomavirus (HPV) Associated Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Human papillomavirus (HPV) Associated Cancer, complete with comparative analysis at various stages,...
$2000
Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Systemic Sclerosis (Scleroderma) Pipeline Review, H1 2015, provides an overview of the Systemic Sclerosis (Scleroderma)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Systemic Sclerosis (Scleroderma), complete with comparative analysis at various stages, therapeutics assessment by drug target,...
$2000
Alopecia - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Direct’s, ‘Alopecia Pipeline Review, H1 2015’, provides an overview of the Alopecia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Alopecia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration...
$2000
Moderate Pain - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Moderate Pain Pipeline Review, H1 2015, provides an overview of the Moderate Pains therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Moderate Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and...
$2000
Myelofibrosis - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Myelofibrosis Pipeline Review, H1 2015, provides an overview of the Myelofibrosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myelofibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and...
$2000
Indolent Lymphoma - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Indolent Lymphoma Pipeline Review, H1 2015, provides an overview of the Indolent Lymphomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Indolent Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration...
$2000
Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Reflux Esophagitis (Gastroesophageal Reflux Disease) Pipeline Review, H1 2015, provides an overview of the Reflux Esophagitis (Gastroesophageal Reflux Disease)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Reflux Esophagitis (Gastroesophageal Reflux Disease), complete with comparative analysis at...
$2000
Gauchers Disease - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Gaucher's Disease Pipeline Review, H1 2015, provides an overview of the Gaucher's Diseases therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Gaucher's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration...
$2000
Degenerative Disc Disease - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Degenerative Disc Disease Pipeline Review, H1 2015, provides an overview of the Degenerative Disc Diseases therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Degenerative Disc Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA),...
$2000
Vasculitis - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Vasculitis Pipeline Review, H1 2015, provides an overview of the Vasculitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Vasculitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule...
$2000
Secondary Hyperparathyroidism - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Secondary Hyperparathyroidism Pipeline Review, H1 2015, provides an overview of the Secondary Hyperparathyroidisms therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Secondary Hyperparathyroidism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of...
$2000
Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Anaplastic Large Cell Lymphoma (ALCL) Pipeline Review, H1 2015, provides an overview of the Anaplastic Large Cell Lymphoma (ALCL)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Anaplastic Large Cell Lymphoma (ALCL), complete with comparative analysis at various stages, therapeutics assessment by drug...
$2000
Intermittent Claudication - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Intermittent Claudication Pipeline Review, H1 2015, provides an overview of the Intermittent Claudications therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Intermittent Claudication, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA),...
$2000
Urinary Incontinence - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Urinary Incontinence Pipeline Review, H1 2015, provides an overview of the Urinary Incontinences therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Urinary Incontinence, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of...
$2000
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Pipeline Review, H1 2015, provides an overview of the Mucopolysaccharidosis I (MPS I) (Hurler Syndrome)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome), complete with comparative analysis at various...
$2000
Chronic Plaque Psoriasis - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Chronic Plaque Psoriasis Pipeline Review, H1 2015, provides an overview of the Chronic Plaque Psoriasiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Plaque Psoriasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA),...
$2000
Constipation - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Constipation Pipeline Review, H1 2015, provides an overview of the Constipations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Constipation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and...
$2000
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015
Jan 2015   |   By - Global Markets Direct
Global Markets Directs, Secondary Progressive Multiple Sclerosis (SPMS) Pipeline Review, H1 2015, provides an overview of the Secondary Progressive Multiple Sclerosis (SPMS)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Secondary Progressive Multiple Sclerosis (SPMS), complete with comparative analysis at various stages,...
$2000
 
Displaying 1 to 30 (of 235 records)

Diseases & Conditions Market Research Reports & Industry Analysis

The global market figure for infectious disease & conditions as well as diagnostic, vaccines, and pharmaceutical products was valued at $59.2 billion in 2011. This is further projected to reach a figure of $96.8 billion by the year 2017 at an annual growth rate (CAGR) of 7.8%. 
Diseases are generally more serious in nature. Diseases and conditions cover the market forecasting and market size for medical devices or disease treatments that are associated for a given disease. 
Over the years, the diagnosis and understanding of the diseases and condition has evolved and improved, and the industry has shown continuous growth and progress in the U.S. and other global markets. Also, the pharmaceuticals and healthcare market has been increasingly showing great results and more changes through laws and regulations. 
The ResearchMoz diseases & conditions market research reports provide a basic understanding of the key factors about a particular disease, its treatment, and its related conditions. Our reports provide an overview of the disease and related conditions, with related prevalence, incidence, and mortality numbers and percentages for prominent business orientated countries worldwide. All the research reports are put together by our team of expert analysts who have used their primary and secondary data sources to cater industry rich reports to the customers. 
If you require all the information you need on diseases & conditions market research and analysis, ResearchMoz is your constant source of information that serves you with intelligent market reports. 

Diseases & Conditions

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData